HIV Drug Stops Cervical Cancer in Laboratory Test
Posted on: Friday, 25 August 2006, 04:25 CDT
LONDON -- A commonly used HIV medicine may also help prevent cervical cancer and could be developed into an anti-cancer cream, early laboratory tests by British scientists suggest.
Researchers at the University of Manchester said on Friday that test-tube studies showed the drug lopinavir selectively killed human papilloma virus (HPV) -- the virus that causes cervical cancer -- as well as HIV.
Lopinavir belongs to a class of HIV drugs known as protease inhibitors. It is a key component of Abbott Laboratories Inc's best-selling pill Kaletra.
Dr Ian Hampson and his colleagues in Manchester believe lopinavir could eventually be made into a simple cream or pessary, offering an alternative to surgery for women with precancerous lesions.
No clinical trials have yet commenced, however.
Results of the team's early research will be published in next month's issue of the journal Anti-Viral Therapy and will also be presented at the International HPV meeting in Prague on September 5.
Merck & Co Inc and GlaxoSmithKline Plc have both developed ground-breaking vaccines to prevent strains of HPV that cause most cases of cervical cancer.
But Hampson said not all women would be vaccinated and not all lesions would be prevented by the new shots, leaving a role for non-surgical therapies such as his team's proposed cream.
Source: REUTERS
Related Articles
- Study Shows Skin Cancer Cream Also Reveals Youthful Skin
- With Assistance From U.S. State Department's 'Bio-Industry Initiative' (BII) Program, Grant Life Sciences In-Licenses Proprietary Technology From Two Russian Scientists That Detects Presence of Cervical Cancer-Causing HPV Types
- AUDIO From Medialink and the Gynecologic Cancer Foundation: Preventing Cervical Cancer
- Merck Joins Celebra Health Campaign in Its Hispanic Community Outreach Effort to Educate Latinas on Cervical Cancer and HPV
- Online Support Network Tool for Cervical Cancer and HPV Community
- Multicell Technologies Demonstrates Drug Candidate's Powerful Tumor-Destroying Capabilities for Virally Induced Cancers Such As Cervical Cancer
- Women Urged to Get Screened for Cervical Cancer During January, Cervical Cancer Screening Month
- Cervical Cancer Elimination Focus of National Public Health Summit
- Experimental Cervical Cancer Vaccine Shows Promise
 |
 |
User Comments (0)
RSS Feeds